Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Baxalta Expands Global Reach of ADYNOVATE for Hemophilia A Patients with Approval in Japan Apr 04, 2016 Nektar Therapeutics to Present at Cowen and Company's 36th Annual Health Care Conference in Boston, MA Mar 03, 2016 Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results Mar 01, 2016 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2015 on Tuesday, March 1, 2016, After Close of U.S.-Based Financial Markets Feb 26, 2016 Baxalta Announces Submission of Supplemental BLAs to Expand Use of ADYNOVATE to Pediatric Patients and Surgical Settings Feb 25, 2016 Nektar Publishes Pre-clinical Results for NKTR-214, an Investigational CD122-Biased Immune-Stimulatory Cytokine for the Treatment of Cancer in Clinical Cancer Research Feb 01, 2016 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 06, 2016 Nektar Therapeutics to Present at Oppenheimer 26th Annual Healthcare Conference in New York Dec 08, 2015 Nektar Announces First Patient Dosed in Phase 1/2 Clinical Study of NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine Dec 08, 2015 Baxalta Presents Additional Data on Newly-Approved ADYNOVATE and Plans for New Indications During 57th American Society of Hematology (ASH) Annual Meeting Dec 07, 2015 Pagination First page « first Previous page ‹ previous … Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Page 26 Page 27 … Next page next › Last page last »